Skip to main content
Premium Trial:

Request an Annual Quote

Scienion, Axela Ink Joint Array Development Agreement

NEW YORK (GenomeWeb) – German sample preparation firm Scienion and Canadian molecular diagnostics firm Axela today announced they have signed a joint marketing and development agreement to create and sell production systems and services for diagnostic and research products.

"This will provide commercialization partners with an integrated and scalable offering to address emerging diagnostic markets," including oncology, allergy, infectious disease, and other markets, the firms said in a statement.

Axela sells a variety of flow-through array technologies. "Our printing requirements are unique," Axela President Paul Smith said. "A precise and versatile liquid handling technology was necessary to meet these demanding requirements, while still providing our partners with a robust, go-to market production solution."

Financial and other details of the agreement were not disclosed.

Over the past year, Scienion has partnered with several firms including Grenier Bio-One, Axxin, Anteo, and QuantuMDx to incorporate its liquid handling and other sample prep technologies into various diagnostic tests and platforms.

Recently, Axela launched a collaboration with Pathology Associates Medical Laboratories to create multiplex assays to detect patient immunity to diseases that can be prevented with vaccines.

 

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.